“Impact of a Prognostic 40-Gene Expression Profiling Test on Clinical Management Decisions for High-Risk Cutaneous Squamous Cell Carcinoma”, J of Skin, vol. 4, no. 5, p. s64, Sep. 2020, doi: 10.25251/skin.4.supp.63.